SCHEMBL308791

SCHEMBL308791

Clc1ccc(-c2ccc(Cl)c(Cl)c2Cl)c(Cl)c1Cl

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
AHR P35869 7/20 0.62
CYP3A4 P08684 2/20 0.50
MAPK1 P28482 1/20 0.50
CES1 P23141 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
CYP2A6 P11509 2/20 0.38
ALPL P05186 2/20 0.36
CYP1A2 P05177 1/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 1/20 0.33
NOTUM Q6P988 1/20 0.33
CYP1B1 Q16678 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811508 0.86 AHR (0.50) AHRCYP3A4MAPK1CYP2A6CYP1A2
SCHEMBL2229300 0.86 AHR (0.62) AHRCYP3A4MAPK1CES1TDP1
SCHEMBL29450677 0.86 AHR (0.62) AHRCYP3A4MAPK1CES1TDP1
SCHEMBL348089 0.84 CYP3A4 (0.62) AHRCYP3A4MAPK1TDP1CYP2A6
SCHEMBL29368277 0.84 CYP3A4 (0.62) AHRCYP3A4MAPK1TDP1CYP2A6
SCHEMBL2935720 0.84 AHR (0.48) AHRCYP3A4MAPK1CYP2A6CYP1A2
SCHEMBL4459622 0.84 AHR (0.60) AHRCYP3A4MAPK1CES1ALPL
SCHEMBL29366530 0.84 AHR (0.60) AHRCYP3A4MAPK1CES1ALPL
SCHEMBL4453307 0.82 AHR (0.52) AHRCYP3A4MAPK1CES1TDP1
SCHEMBL2230317 0.82 AHR (0.52) AHRCYP3A4MAPK1CES1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051430-A1 NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION Institut National de la Santé et de la Recherche Médicale (FR) 2025-02-13 US claimed
CN-119361834-A Electrolyte and battery and electricity utilization device containing same 浙江大学 2025-01-24 CN claimed
EP-4475883-A1 NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2024-12-18 EP claimed
CN-118922206-A Neutralization of acetyl-CoA binding proteins confers autophagy-dependent organ protection 国家医疗保健研究所 2024-11-08 CN claimed
CN-116893235-A Method and kit for determining polychlorinated biphenyl and multi-class brominated flame retardant residues in traditional Chinese medicine 江苏省食品药品监督检验研究院(江苏省食品质量安全监控中心) 2023-10-17 CN claimed
WO-2023152637-A1 NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2023-08-17 WO claimed
CN-114814013-B Method for rapidly screening unknown chemical hazard residues in aquatic products based on high-resolution mass spectrum database 中国海洋大学 2023-06-02 CN claimed
CN-111308003-B Method for simultaneously detecting diisopropylnaphthalenes, polychlorinated biphenyls, phthalate compounds and photoinitiator 福建中烟工业有限责任公司 2022-11-08 CN claimed
US-20220351865-A1 METHODS OF BIOLOGICAL AGE EVALUATION AND SYSTEMS USING SUCH METHODS GERO PTE. LTD. (SG) 2022-11-03 US claimed
CN-111665313-B Method for determining polychlorinated biphenyl compounds in aquatic products 孟祥龙 2022-10-11 CN claimed
CN-107929997-B Application of rape stalk biochar in mediating polychlorinated biphenyl anaerobic reduction dechlorination 浙江大学 2020-06-23 CN claimed
CN-110612119-A Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents 西雅图儿童医院(DBA西雅图儿童研究所) 2019-12-24 CN claimed
WO-2018148224-A1 PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) 2018-08-16 WO claimed
US-20140170174-A1 POLYCHLORINATED BIPHENYLS AND SQUALENE-CONTAINING ADJUVANTS NOVARTIS AG (CH) 2014-06-19 US claimed
US-20120195931-A1 POLYCHLORINATED BIPHENYLS AND SQUALENE-CONTAINING ADJUVANTS Seqirus UK Limited (GB) 2012-08-02 US claimed
US-8092813-B1 Polychlorinated biphenyls and squalene-containing adjuvants NOVARTIS AG (CH) 2012-01-10 US claimed
US-20060281961-A1 Functional transition metal silicates KANUMURU RAHUL RAJU (IN) 2006-12-14 US claimed
US-6544773-B1 For degrading different congeners namely coplanar, sterically hindered and other chlorobiphenyls COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2003-04-08 US claimed
US-20030054538-A1 Microbial process for degradation of PCBs in clophen A-50 using a novel marine microorganism, pseudomonas CH07 SARKAR ANUPAM (IN) 2003-03-20 US claimed
US-4024093-A Flame retardant polyphenylene ether resin compositions containing a halogenated flame retardant and selected organic iron salts GENERAL ELECTRIC COMPANY (US) 1977-05-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120195931-A1 POLYCHLORINATED BIPHENYLS AND SQUALENE-CONTAINING ADJUVANTS SQLE, TLR5, FDFT1 AHR 17/4885CYP3A4 3030/4885MAPK1 4272/4885
US-20140170174-A1 POLYCHLORINATED BIPHENYLS AND SQUALENE-CONTAINING ADJUVANTS SQLE, TLR5, FDFT1 AHR 17/4885CYP3A4 3030/4885MAPK1 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.